AU2007320931A1 - Clotrimazol for treating staphylococcal infections - Google Patents

Clotrimazol for treating staphylococcal infections Download PDF

Info

Publication number
AU2007320931A1
AU2007320931A1 AU2007320931A AU2007320931A AU2007320931A1 AU 2007320931 A1 AU2007320931 A1 AU 2007320931A1 AU 2007320931 A AU2007320931 A AU 2007320931A AU 2007320931 A AU2007320931 A AU 2007320931A AU 2007320931 A1 AU2007320931 A1 AU 2007320931A1
Authority
AU
Australia
Prior art keywords
clotrimazole
agent
methicillin resistant
resistant staphylococcus
staphylococcus species
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2007320931A
Other languages
English (en)
Inventor
Julie Anne Charlton
Olosola Clement IDOWU
Catherine Mary Yates
Malcolm Philip Young
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
E Therapeutics PLC
Original Assignee
E Therapeutics Ltd
E Therapeutics PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0622841A external-priority patent/GB0622841D0/en
Priority claimed from GB0711704A external-priority patent/GB0711704D0/en
Application filed by E Therapeutics Ltd, E Therapeutics PLC filed Critical E Therapeutics Ltd
Publication of AU2007320931A1 publication Critical patent/AU2007320931A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2007320931A 2006-11-16 2007-11-15 Clotrimazol for treating staphylococcal infections Abandoned AU2007320931A1 (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
GB0622841.5 2006-11-16
GB0622841A GB0622841D0 (en) 2006-11-16 2006-11-16 Treatment of staphylococcal infections
GB0711704A GB0711704D0 (en) 2007-06-13 2007-06-13 Treatment of staphylococcal infections
GB0711704.7 2007-06-13
US96784007P 2007-09-07 2007-09-07
US60/967,840 2007-09-07
PCT/GB2007/004373 WO2008059261A1 (en) 2006-11-16 2007-11-15 Clotrimazol for treating staphylococcal infections

Publications (1)

Publication Number Publication Date
AU2007320931A1 true AU2007320931A1 (en) 2008-05-22

Family

ID=38982622

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2007320931A Abandoned AU2007320931A1 (en) 2006-11-16 2007-11-15 Clotrimazol for treating staphylococcal infections

Country Status (6)

Country Link
EP (1) EP2094264A1 (ja)
JP (1) JP2010510200A (ja)
KR (1) KR20090100358A (ja)
AU (1) AU2007320931A1 (ja)
CA (1) CA2669594A1 (ja)
WO (1) WO2008059261A1 (ja)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0724996D0 (en) * 2007-12-21 2008-01-30 Therapeutics Ltd E Antibacterial combination therapy for the treatment of gram positive bacterial infections
TWI834808B (zh) * 2019-02-19 2024-03-11 西班牙商薩爾瓦特實驗室有限公司 以單劑包裝的克氯黴唑液體組成物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7601731B2 (en) * 2003-06-06 2009-10-13 Board Of Regents, The University Of Texas System Antimicrobial flush solutions
EP1737378A2 (en) * 2004-04-02 2007-01-03 Baylor College of Medicine Novel modification of medical prostheses

Also Published As

Publication number Publication date
EP2094264A1 (en) 2009-09-02
KR20090100358A (ko) 2009-09-23
WO2008059261A1 (en) 2008-05-22
CA2669594A1 (en) 2008-05-22
JP2010510200A (ja) 2010-04-02

Similar Documents

Publication Publication Date Title
EP2328573B1 (en) Antibacterial combination therapy for the treatment of gram positive bacterial infections
RU2560846C1 (ru) Фармацевтические композиции, содержащие сулбактам и ингибитор бета-лактамазы
US11324715B2 (en) Bismuth-thiol compositions and methods for treating wounds
EP2094358B1 (en) Imidazoles for treating multi-drug resistant bacterial infections
US20110039906A1 (en) Antibacterial combination therapy
AU2007320931A1 (en) Clotrimazol for treating staphylococcal infections
WO2009081117A1 (en) Antibacterial combination therapy for the treatment of gram positive bacterial infections
US12036200B2 (en) Bismuth-thiol compositions and methods for treating wounds
JP2008534443A (ja) 新規な方法

Legal Events

Date Code Title Description
MK1 Application lapsed section 142(2)(a) - no request for examination in relevant period